Stayble Therapeutics AB (publ) (FRA:4K4)

Market Cap	1.28M -23.9%
Revenue (ttm)	n/a
Net Income	-761.30K
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0167
Previous Close	0.0172
Day's Range	0.0162 - 0.0167
52-Week Range	0.0127 - 0.0528
Beta	n/a
RSI	48.66
Earnings Date	Feb 20, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2015
• Employees: 2
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4K4

Financial Performance

Financial numbers in SEK